| Study Period | |||||||
---|---|---|---|---|---|---|---|---|
 | Enrollment | Allocation | Post-allocation | closeout | ||||
Time point | -t1 | 0 | t1 | t2 | t3 | t4 | t5 | t6 |
Enrollment: | Â | Â | Â | Â | Â | Â | Â | Â |
Eligibility screen | × |  |  |  |  |  |  |  |
Informed consent | × |  |  |  |  |  |  |  |
Allocation |  | × |  |  |  |  |  |  |
Interventions: | Â | Â | Â | Â | Â | Â | Â | Â |
Control group | Â | Â | Â | Â | Â | Â | Â | Â |
Experimental group I |  |  | × | × | × | × |  |  |
Experimental group II |  |  | × | × | × | × |  |  |
Experimental group III |  |  | × | × | × | × |  |  |
Assessments: | Â | Â | Â | Â | Â | Â | Â | Â |
baseline variables | × | × |  |  |  |  |  |  |
The frequency of nausea and vomiting |  | × | × | × | × | × | × | × |
The grading of nausea and vomiting |  | × | × | × | × | × | × | × |
Rhodes Index of nausea, vomiting and retching |  | × | × | × | × | × | × | × |
the grading of constipation and diarrhea |  | × | × | × | × | × |  | × |
electrogastrogram |  | × |  |  |  |  | × | × |
the assessment of quality of life |  | × |  |  |  |  | × | × |
the assessment of anxiety and depression |  | × |  |  |  |  | × | × |
other adverse effect during the chemotherapy |  |  |  |  |  |  | × | × |
the adverse effects of acupuncture |  |  | × | × | × | × |  |  |